ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7H14348
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global 1 4 Alpha Glucan Branching Enzyme GBE1 Antibody Market Research Report 2023
BUY CHAPTERS

Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Research Report 2025

Code: QYRE-Auto-7H14348
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sino Biological Inc
Cell Signaling Technology Inc
Bio-Techne
OriGene Technologies, Inc.
Creative-Biolabs
GeneTex
Arigo Biolaboratories Corp
Abcam
RayBiotech
Biomatik
Assay Genie
BioLegend

1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market

The global market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody in Flow Cytometry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody include Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Abcam, RayBiotech, Inc., Biomatik, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody.
The 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Report

Report Metric Details
Report Name 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market
Segment by Type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segment by Application
  • Flow Cytometry
  • ELISA
  • Western Blot
  • Immunoprecipitation
  • Immunofluorescence
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Abcam, RayBiotech, Inc., Biomatik, Assay Genie, BioLegend
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report?

Ans: The main players in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market are Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Abcam, RayBiotech, Inc., Biomatik, Assay Genie, BioLegend

What are the Application segmentation covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report?

Ans: The Applications covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report are Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Other

What are the Type segmentation covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report?

Ans: The Types covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Perspective (2020-2031)
2.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Growth Trends by Region
2.2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Historic Market Size by Region (2020-2025)
2.2.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Region (2026-2031)
2.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Dynamics
2.3.1 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Industry Trends
2.3.2 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Drivers
2.3.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Challenges
2.3.4 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Revenue
3.1.1 Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Revenue (2020-2025)
3.1.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Players (2020-2025)
3.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue
3.4 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Concentration Ratio
3.4.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue in 2024
3.5 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Head office and Area Served
3.6 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Product and Application
3.7 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Breakdown Data by Type
4.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Historic Market Size by Type (2020-2025)
4.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Type (2026-2031)
5 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Breakdown Data by Application
5.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Historic Market Size by Application (2020-2025)
5.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)
6.2 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)
6.4 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)
7.2 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)
7.4 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)
8.2 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)
9.2 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)
9.4 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)
10.2 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Details
11.1.2 Sino Biological, Inc. Business Overview
11.1.3 Sino Biological, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.1.4 Sino Biological, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.1.5 Sino Biological, Inc. Recent Development
11.2 Cell Signaling Technology, Inc.
11.2.1 Cell Signaling Technology, Inc. Company Details
11.2.2 Cell Signaling Technology, Inc. Business Overview
11.2.3 Cell Signaling Technology, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.2.4 Cell Signaling Technology, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.2.5 Cell Signaling Technology, Inc. Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Details
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.3.4 Bio-Techne Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.3.5 Bio-Techne Recent Development
11.4 OriGene Technologies, Inc.
11.4.1 OriGene Technologies, Inc. Company Details
11.4.2 OriGene Technologies, Inc. Business Overview
11.4.3 OriGene Technologies, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.4.4 OriGene Technologies, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.4.5 OriGene Technologies, Inc. Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.5.4 Creative Biolabs Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.5.5 Creative Biolabs Recent Development
11.6 GeneTex
11.6.1 GeneTex Company Details
11.6.2 GeneTex Business Overview
11.6.3 GeneTex 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.6.4 GeneTex Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.6.5 GeneTex Recent Development
11.7 Arigo Biolaboratories Corp.
11.7.1 Arigo Biolaboratories Corp. Company Details
11.7.2 Arigo Biolaboratories Corp. Business Overview
11.7.3 Arigo Biolaboratories Corp. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.7.4 Arigo Biolaboratories Corp. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.7.5 Arigo Biolaboratories Corp. Recent Development
11.8 Abcam
11.8.1 Abcam Company Details
11.8.2 Abcam Business Overview
11.8.3 Abcam 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.8.4 Abcam Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.8.5 Abcam Recent Development
11.9 RayBiotech, Inc.
11.9.1 RayBiotech, Inc. Company Details
11.9.2 RayBiotech, Inc. Business Overview
11.9.3 RayBiotech, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.9.4 RayBiotech, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.9.5 RayBiotech, Inc. Recent Development
11.10 Biomatik
11.10.1 Biomatik Company Details
11.10.2 Biomatik Business Overview
11.10.3 Biomatik 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.10.4 Biomatik Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.10.5 Biomatik Recent Development
11.11 Assay Genie
11.11.1 Assay Genie Company Details
11.11.2 Assay Genie Business Overview
11.11.3 Assay Genie 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.11.4 Assay Genie Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.11.5 Assay Genie Recent Development
11.12 BioLegend
11.12.1 BioLegend Company Details
11.12.2 BioLegend Business Overview
11.12.3 BioLegend 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
11.12.4 BioLegend Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
11.12.5 BioLegend Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sino Biological Inc
Cell Signaling Technology Inc
Bio-Techne
OriGene Technologies, Inc.
Creative-Biolabs
GeneTex
Arigo Biolaboratories Corp
Abcam
RayBiotech
Biomatik
Assay Genie
BioLegend
List of Tables
 Table 1. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibody
 Table 3. Key Players of Polyclonal Antibody
 Table 4. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region (2020-2025)
 Table 8. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region (2026-2031)
 Table 10. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Trends
 Table 11. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Drivers
 Table 12. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Challenges
 Table 13. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Restraints
 Table 14. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Players (2020-2025)
 Table 16. Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody as of 2024)
 Table 17. Ranking of Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Headquarters and Area Served
 Table 20. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Product and Application
 Table 21. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Sino Biological, Inc. Company Details
 Table 47. Sino Biological, Inc. Business Overview
 Table 48. Sino Biological, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 49. Sino Biological, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 50. Sino Biological, Inc. Recent Development
 Table 51. Cell Signaling Technology, Inc. Company Details
 Table 52. Cell Signaling Technology, Inc. Business Overview
 Table 53. Cell Signaling Technology, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 54. Cell Signaling Technology, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 55. Cell Signaling Technology, Inc. Recent Development
 Table 56. Bio-Techne Company Details
 Table 57. Bio-Techne Business Overview
 Table 58. Bio-Techne 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 59. Bio-Techne Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 60. Bio-Techne Recent Development
 Table 61. OriGene Technologies, Inc. Company Details
 Table 62. OriGene Technologies, Inc. Business Overview
 Table 63. OriGene Technologies, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 64. OriGene Technologies, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 65. OriGene Technologies, Inc. Recent Development
 Table 66. Creative Biolabs Company Details
 Table 67. Creative Biolabs Business Overview
 Table 68. Creative Biolabs 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 69. Creative Biolabs Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 70. Creative Biolabs Recent Development
 Table 71. GeneTex Company Details
 Table 72. GeneTex Business Overview
 Table 73. GeneTex 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 74. GeneTex Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 75. GeneTex Recent Development
 Table 76. Arigo Biolaboratories Corp. Company Details
 Table 77. Arigo Biolaboratories Corp. Business Overview
 Table 78. Arigo Biolaboratories Corp. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 79. Arigo Biolaboratories Corp. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 80. Arigo Biolaboratories Corp. Recent Development
 Table 81. Abcam Company Details
 Table 82. Abcam Business Overview
 Table 83. Abcam 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 84. Abcam Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 85. Abcam Recent Development
 Table 86. RayBiotech, Inc. Company Details
 Table 87. RayBiotech, Inc. Business Overview
 Table 88. RayBiotech, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 89. RayBiotech, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 90. RayBiotech, Inc. Recent Development
 Table 91. Biomatik Company Details
 Table 92. Biomatik Business Overview
 Table 93. Biomatik 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 94. Biomatik Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 95. Biomatik Recent Development
 Table 96. Assay Genie Company Details
 Table 97. Assay Genie Business Overview
 Table 98. Assay Genie 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 99. Assay Genie Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 100. Assay Genie Recent Development
 Table 101. BioLegend Company Details
 Table 102. BioLegend Business Overview
 Table 103. BioLegend 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
 Table 104. BioLegend Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)
 Table 105. BioLegend Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Picture
 Figure 2. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibody Features
 Figure 5. Polyclonal Antibody Features
 Figure 6. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Flow Cytometry Case Studies
 Figure 9. ELISA Case Studies
 Figure 10. Western Blot Case Studies
 Figure 11. Immunoprecipitation Case Studies
 Figure 12. Immunofluorescence Case Studies
 Figure 13. Other Case Studies
 Figure 14. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Report Years Considered
 Figure 15. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region: 2024 VS 2031
 Figure 18. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Players in 2024
 Figure 19. Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue in 2024
 Figure 21. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)
 Figure 23. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)
 Figure 27. Germany 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region (2020-2031)
 Figure 35. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)
 Figure 43. Mexico 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)
 Figure 47. Turkey 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Sino Biological, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 51. Cell Signaling Technology, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 52. Bio-Techne Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 53. OriGene Technologies, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 54. Creative Biolabs Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 55. GeneTex Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 56. Arigo Biolaboratories Corp. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 57. Abcam Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 58. RayBiotech, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 59. Biomatik Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 60. Assay Genie Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 61. BioLegend Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global A glucan Oligosaccharide Market Research Report 2025
Enzyme Immunoassay Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global J Chain Antibody Market Research Report 2024
Global GFAP Antibody Market Research Report 2024
Global JAG1 Antibody Market Research Report 2024
Global Erk1 Antibody Market Research Report 2024
Global EXT1 Antibody Market Research Report 2025
Global β Agarase Market Research Report 2025
Global Glucobay Market Research Report 2024
Global PECAM 1 Antibody Market Research Report 2024
Global ALK 1 Antibody Market Research Report 2024
Hemagglutinin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GNS Glucosamine GNS Antibody Market Research Report 2025
Hemojuvelin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PARP1 Antibody Market Research Report 2024
Global In vitro Glyco Engineering IVGE Market Research Report 2025
Global β Glucuronidase Enzymes Market Research Report 2025
Fully Automatic Glycated Hemoglobin Analysis System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibodies Market Research Report 2024
Global G Protein Coupled Bile Acid Receptor 1 Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions